Design Therapeutics (DSGN) Return on Assets (2021 - 2026)
Design Therapeutics (DSGN) posted quarterly Return on Assets of 0.0% for Q2 2026, little changed year-over-year from 0.0% in Q2 2025, and down 4.48% on a QoQ basis from 0.0% in Q1 2026.
Design Therapeutics (DSGN) Return on Assets (2021 - 2026) Analysis & Trends
Design Therapeutics has reported Return on Assets for 6 years, with the latest figure at 0.0% in Q2 2026.
- Return on Assets for Q2 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 2.25%, down 152.0% from the prior year.
- Return on Assets fell to 0.0% in Q2 2026, from 0.0% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q1 2022 and troughed at 0.35% in Q3 2023.
- A 5-year average of 0.07% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
- The widest annual swing landed in 2023, when Return on Assets slumped 35 bps; it then soared 34 bps in 2024.
- A 5-year view of Return on Assets shows it stood at 0.31% in 2022, then jumped by 99 bps to 0.0% in 2023, then soared by 44 bps to 0.0% in 2024, then sank by 58 bps to 0.0% in 2025, then declined by 1 bps to 0.0% in 2026.
- Per Business Quant data, the three most recent Return on Assets figures were 0.0% in Q2 2026, 0.0% in Q1 2026, and 0.0% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.01% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Design Therapeutics | 928.06 Mn | 720.67 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |